COSCIENS Biopharma Inc. (TSX:CSCI)
Canada · Delayed Price · Currency is CAD 2.850
+0.020 (0.71%)
Apr 10, 2026, 3:13 PM EST
COSCIENS Biopharma Market Cap
COSCIENS Biopharma has a market cap or net worth of CAD 9.07 million as of April 10, 2026. Its market cap has increased by 25.28% in one year.
Market Cap
9.07M
Enterprise Value
2.00M
Revenue
10.28M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.85
Market Cap Chart
Since April 22, 1996, COSCIENS Biopharma's market cap has decreased from 14.82B to 9.07M, a decrease of -99.94%. That is a compound annual growth rate of -21.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 9.07M | 0.38% |
| Dec 31, 2025 | 9.04M | 30.63% |
| Dec 31, 2024 | 6.92M | -44.54% |
| Dec 29, 2023 | 12.48M | -40.23% |
| Dec 30, 2022 | 20.88M | -62.20% |
| Dec 31, 2021 | 55.24M | 63.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rapid Dose Therapeutics | 16.22M |
| Britannia Life Sciences | 14.60M |
| Hemostemix | 13.85M |
| PreveCeutical Medical | 11.96M |
| Pharmala Biotech Holdings | 10.89M |
| Marvel Biosciences | 10.40M |
| Glow Lifetech | 9.61M |
| Innovotech | 9.53M |